Search Results for "fondaparinux"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for fondaparinux. Results 11 to 13 of 13 total matches.
See also: Arixtra
New Oral Anticoagulants for Acute Venous Thromboembolism
The Medical Letter on Drugs and Therapeutics • Jan 06, 2014 (Issue 1433)
weight heparin (LMWH), or fondaparinux
(Arixtra, and generics); all are associated with similar
rates ...
Anticoagulants are the drugs of choice for treatment
of deep vein thrombosis (DVT) and pulmonary
embolism (PE), collectively referred to as venous
thromboembolism (VTE).
Edoxaban (Savaysa) - The Fourth New Oral Anticoagulant
The Medical Letter on Drugs and Therapeutics • Mar 30, 2015 (Issue 1465)
anticoagulant such as
unfractionated heparin, low molecular weight heparin
(LMWH), or fondaparinux (Arixtra ...
The FDA has approved edoxaban (Savaysa – Daiichi
Sankyo), a once-daily, oral, direct factor Xa inhibitor,
for treatment of venous thromoboembolism (VTE)
and for prevention of stroke and systemic embolism
in patients with nonvalvular atrial fibrillation. It is the
fourth new oral anticoagulant to be approved for VTE
and nonvalvular atrial fibrillation.
Comparison Table: Some Oral Anticoagulants for VTE (online only)
The Medical Letter on Drugs and Therapeutics • Jul 25, 2022 (Issue 1655)
effect
For treatment of VTE, requires overlap with LMWH,
fondaparinux, or UFH for ≥5 days and until INR ...
View the Comparison Table: Some Oral Anticoagulants for VTE